Lexaria Bioscience Corp.
LEXX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348362
No open-market purchases or sales by Lexaria Bioscience Corp. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $920.0K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Lexaria Bioscience Corp. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 12 | 16 | +4 |
| Shares | 472.6K | 561.7K | +89.1K (+18.8%) |
| Value | $1.41M | $1.67M | +$263.0K (+18.7%) |
New holders (6)
Institutions that held Lexaria Bioscience Corp. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 27,888 | $83.0K | 0.00% |
| Merit Financial Group, LLC | 21,267 | $63.0K | 0.00% |
| Two Sigma Investments, LP | 17,401 | $52.0K | 0.00% |
| Centiva Capital, LP | 14,159 | $42.0K | 0.00% |
| Renaissance Technologies LLC | 11,500 | $34.0K | 0.00% |
| Citigroup Inc | 1,230 | $4.00K | 0.00% |
Sold out (2)
Institutions that held Lexaria Bioscience Corp. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 3,056 | $10.0K |
| 1832 Asset Management L.P. | 2,686 | $9.00K |